Future drug discovery in renin-angiotensin-aldosterone system intervention
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 9, 2017 Category: Drugs & Pharmacology Authors: Maria Tamargo Juan Tamargo Source Type: research

The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 8, 2017 Category: Drugs & Pharmacology Authors: Tao Wang Xin-song Yuan Mian-Bin Wu Jian-Ping Lin Li-Rong Yang Source Type: research

Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 7, 2017 Category: Drugs & Pharmacology Authors: Boris Kubuschok Martin Trepel Source Type: research

Novel approaches to develop community-built biological network models for potential drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 6, 2017 Category: Drugs & Pharmacology Authors: Marja Talikka Natalia Bukharov William S. Hayes Martin Hofmann-Apitius Leonidas Alexopoulos Manuel C. Peitsch Julia Hoeng Source Type: research

Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn ’s disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 2, 2017 Category: Drugs & Pharmacology Authors: Laurel K. Mydock-McGrane Thomas J. Hannan James W. Janetka Source Type: research

New routes in frontotemporal dementia drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 2, 2017 Category: Drugs & Pharmacology Authors: Laura De Conti Barbara Borroni Marco Baralle Source Type: research

Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn ’s disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 2, 2017 Category: Drugs & Pharmacology Authors: Laurel K. Mydock-McGrane Thomas J. Hannan James W. Janetka Source Type: research

New routes in frontotemporal dementia drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 2, 2017 Category: Drugs & Pharmacology Authors: Laura De Conti Barbara Borroni Marco Baralle Source Type: research

The preclinical discovery of vosaroxin for the treatment of acute myeloid leukemia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: Etienne Paubelle Florence Zylbersztejn Xavier Thomas Source Type: research

Understanding sleep-wake mechanisms and drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: Ana Clementina Equihua-Ben ítez Khalil Guzm án-Vásquez Ren é Drucker-Colín Source Type: research

Harnessing public domain data to discover and validate therapeutic targets
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: William C. Reisdorf Neha Chhugani Philippe Sanseau Pankaj Agarwal Source Type: research

The preclinical discovery of vosaroxin for the treatment of acute myeloid leukemia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: Etienne Paubelle Florence Zylbersztejn Xavier Thomas Source Type: research

Understanding sleep-wake mechanisms and drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: Ana Clementina Equihua-Ben ítez Khalil Guzm án-Vásquez Ren é Drucker-Colín Source Type: research

Harnessing public domain data to discover and validate therapeutic targets
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: William C. Reisdorf Neha Chhugani Philippe Sanseau Pankaj Agarwal Source Type: research

The impact of genetics on future drug discovery in schizophrenia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 19, 2017 Category: Drugs & Pharmacology Authors: Mitsuyuki Matsumoto Noah M. Walton Hiroshi Yamada Yuji Kondo Gerard J. Marek Katsunori Tajinda Source Type: research

Corrigendum
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 17, 2017 Category: Drugs & Pharmacology Source Type: research

Combating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design
Volume 12, Issue 6, June 2017, Page 553-563 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 11, 2017 Category: Drugs & Pharmacology Authors: Amanda T.S. Albanaz Carlos H.M. Rodrigues Douglas E.V. Pires David B. Ascher Source Type: research

Nonhuman primates as models for the discovery and development of radiation countermeasures
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 5, 2017 Category: Drugs & Pharmacology Authors: Vijay K. Singh Ayodele O. Olabisi Source Type: research

Discovery and preclinical development of dasabuvir for the treatment of hepatitis C infection
Volume 12, Issue 6, June 2017, Page 635-642 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 5, 2017 Category: Drugs & Pharmacology Authors: Mohamed El Kassas Tamer Elbaz Enas Hafez Mohamed Naguib Wifi Gamal Esmat Source Type: research

Nonhuman primates as models for the discovery and development of radiation countermeasures
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 5, 2017 Category: Drugs & Pharmacology Authors: Vijay K. Singh Ayodele O. Olabisi Source Type: research

Discovery and preclinical development of dasabuvir for the treatment of hepatitis C infection
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 5, 2017 Category: Drugs & Pharmacology Authors: Mohamed El Kassas Tamer Elbaz Enas Hafez Mohamed Naguib Wifi Gamal Esmat Source Type: research

‘Big data’ approaches for novel anti-cancer drug discovery
Volume 12, Issue 6, June 2017, Page 599-609 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 2, 2017 Category: Drugs & Pharmacology Authors: Graeme Benstead-Hume Sarah K. Wooller Frances M. G. Pearl Source Type: research

Therapeutic targeting and patient selection for cancers with homologous recombination defects
Volume 12, Issue 6, June 2017, Page 565-581 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 2, 2017 Category: Drugs & Pharmacology Authors: Francien Talens Mathilde Jalving Jourik A. Gietema Marcel A. Van Vugt Source Type: research

Therapeutic targeting and patient selection for cancers with homologous recombination defects
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 2, 2017 Category: Drugs & Pharmacology Authors: Francien Talens Mathilde Jalving Jourik A. Gietema Marcel A. Van Vugt Source Type: research

‘Big data’ approaches for novel anti-cancer drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 2, 2017 Category: Drugs & Pharmacology Authors: Graeme Benstead-Hume Sarah K. Wooller Frances M. G. Pearl Source Type: research

Applications of CRISPR genome editing technology in drug target identification and validation
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 24, 2017 Category: Drugs & Pharmacology Authors: Quinn Lu George P. Livi Sundip Modha Kosuke Yusa Ricardo Macarr ón David J. Dow Source Type: research

An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 21, 2017 Category: Drugs & Pharmacology Authors: Wooseong Kim Gabriel Lambert Hendricks Kiho Lee Eleftherios Mylonakis Source Type: research

An overview of quinoline as a privileged scaffold in cancer drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 20, 2017 Category: Drugs & Pharmacology Authors: Robert Musiol Source Type: research

Enhancing the therapeutic potential of peptide toxins
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 20, 2017 Category: Drugs & Pharmacology Authors: Raymond S. Norton Source Type: research

An overview of quinoline as a privileged scaffold in cancer drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 20, 2017 Category: Drugs & Pharmacology Authors: Robert Musiol Source Type: research

Enhancing the therapeutic potential of peptide toxins
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 20, 2017 Category: Drugs & Pharmacology Authors: Raymond S. Norton Source Type: research

Academia –pharma partnerships for novel drug discovery: essential or nice to have?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 18, 2017 Category: Drugs & Pharmacology Authors: Michelle Palmer Rathnam Chaguturu Source Type: research

The utility of target-based discovery
Volume 12, Issue 5, May 2017, Page 427-429 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - March 23, 2017 Category: Drugs & Pharmacology Authors: Glenn E. Croston Source Type: research

The utility of target-based discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - March 23, 2017 Category: Drugs & Pharmacology Authors: Glenn E. Croston Source Type: research

Genome database mining for the discovery of novel lantibiotics
Volume 12, Issue 5, May 2017, Page 489-495 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - March 22, 2017 Category: Drugs & Pharmacology Authors: Stephanie K. Sandiford Source Type: research

Genome database mining for the discovery of novel lantibiotics
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - March 22, 2017 Category: Drugs & Pharmacology Authors: Stephanie K. Sandiford Source Type: research

An overview of Ca2+ mobilization assays in GPCR drug discovery
Volume 12, Issue 5, May 2017, Page 511-523 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - March 17, 2017 Category: Drugs & Pharmacology Authors: Qiang Ma Lingyan Ye Hongxia Liu Ying Shi Naiming Zhou Source Type: research

Challenges in searching for therapeutics against Botulinum Neurotoxins
Volume 12, Issue 5, May 2017, Page 497-510 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - March 17, 2017 Category: Drugs & Pharmacology Authors: Marco Pirazzini Ornella Rossetto Source Type: research

Harnessing the power of proteomics for identification of oncogenic, druggable signalling pathways in cancer
Volume 12, Issue 5, May 2017, Page 431-447 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - March 17, 2017 Category: Drugs & Pharmacology Authors: Heather C. Murray Matthew D. Dun Nicole M. Verrills Source Type: research